Carregant...
Miniatura

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/108186

Sudemycin K: a synthetic anti-tumor splicing inhibitor variant with improved activity and versatile chemistry

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Important links exist between the process of pre-mRNA splicing and cancer, as illustrated by the frequent mutation of splicing factors in tumors and the emergence of various families of antitumor drugs that target components of the splicing machinery, notably SF3B1, a protein subunit of spliceosomal U2 small nuclear ribonucleoprotein particle (snRNP). Sudemycins are synthetic compounds that harbor a pharmacophore common to various classes of splicing inhibitors. Here, we describe the synthesis and functional characterization of novel sudemycin analogues that function- ally probe key functional groups within this pharmacophore. Our results confirm the importance of a conjugated diene group and in addition reveal significant spatial flexibility in this region of the molecule. Sudemycin K, a derivative that replaces the pharmacophore's oxycarbonyl by an amide group, displays improved potency as an inhibitor of cancer cell proliferation, as a regulator of alternative splicing in cultured cells and as an inhibitor of in vitro spliceosome assembly. Sudemycin K displays higher stability, likely related to the replacement of the oxycarbonyl group, which can be a substrate of esterases, by an amide group. The activity and special reactivity of sudemycin K can pave the way to the synthesis and evaluation of a variety of novel sudemycin derivatives.

Matèries (anglès)

Citació

Citació

MAKOWSKI, Kamil, VIGEVANI, Luisa, ALBERICIO PALOMERA, Fernando, VALCÁRCEL, Juan, ÁLVAREZ DOMINGO, Mercedes. Sudemycin K: a synthetic anti-tumor splicing inhibitor variant with improved activity and versatile chemistry. _ACS Chemical Biology_. 2016. Vol. 12, núm. 1, pàgs. 163-173. [consulta: 25 de gener de 2026]. ISSN: 1554-8929. [Disponible a: https://hdl.handle.net/2445/108186]

Exportar metadades

JSON - METS

Compartir registre